Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Biotechnology for Biofuels
|
January 13, 2017
Integrated omics analyses reveal the details of metabolic adaptation of <i>Clostridium thermocellum</i> to lignocellulose-derived growth inhibitors released during the deconstruction of switchgrass
Suresh Poudel, Richard J Giannone, Miguel Rodriguez, et al.
Genome Biology and Evolution
|
December 6, 2012
Polyclonality of concurrent natural populations of Alteromonas macleodii
Aitor Gonzaga, Ana-Belen Martin-Cuadrado, Mario López-Pérez, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
February 26, 2020
Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing
Megan H Cleveland, Bharathi Anekella, Michael Brewer, et al.
Nutrients
|
April 17, 2019
Decaffeinated Green Tea Extract Does Not Elicit Hepatotoxic Effects and Modulates the Gut Microbiome in Lean B6C3F₁ Mice
Bill J Gurley, Isabelle R Miousse, Intawat Nookaew, et al.
Frontiers in Microbiology
|
August 22, 2018
PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
Patrick L Apopa, Lisa Alley, Rosalind B Penney, et al.
Oncotarget
|
June 6, 2026
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Emily Bivens, Omar Atiq, Teresa Evans, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Emily Bivens, Omar Atiq, Teresa Evans, et al.
Nature Biotechnology
|
May 10, 2008
The minimum information about a genome sequence (MIGS) specification
Dawn Field, George Garrity, Tanya Gray, et al.
Nature Biotechnology
|
January 30, 2007
Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88
Herman J Pel, Johannes H de Winde, David B Archer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Biotechnology for Biofuels
|
January 13, 2017
Integrated omics analyses reveal the details of metabolic adaptation of <i>Clostridium thermocellum</i> to lignocellulose-derived growth inhibitors released during the deconstruction of switchgrass
Suresh Poudel, Richard J Giannone, Miguel Rodriguez, et al.
Genome Biology and Evolution
|
December 6, 2012
Polyclonality of concurrent natural populations of Alteromonas macleodii
Aitor Gonzaga, Ana-Belen Martin-Cuadrado, Mario López-Pérez, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
February 26, 2020
Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing
Megan H Cleveland, Bharathi Anekella, Michael Brewer, et al.
Nutrients
|
April 17, 2019
Decaffeinated Green Tea Extract Does Not Elicit Hepatotoxic Effects and Modulates the Gut Microbiome in Lean B6C3F₁ Mice
Bill J Gurley, Isabelle R Miousse, Intawat Nookaew, et al.
Frontiers in Microbiology
|
August 22, 2018
PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
Patrick L Apopa, Lisa Alley, Rosalind B Penney, et al.
Oncotarget
|
June 6, 2026
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Emily Bivens, Omar Atiq, Teresa Evans, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Emily Bivens, Omar Atiq, Teresa Evans, et al.
Nature Biotechnology
|
May 10, 2008
The minimum information about a genome sequence (MIGS) specification
Dawn Field, George Garrity, Tanya Gray, et al.
Nature Biotechnology
|
January 30, 2007
Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88
Herman J Pel, Johannes H de Winde, David B Archer, et al.
Page
of 3